US Patent Issued to The Board of Trustees of the Leland Stanford Junior University, The Regents of the University of California on Oct. 6 for "Methods relating to anti-IL-1 therapy and anti-IL-6 therapy and hypersensitivity" (California Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,443, issued on Oct. 6, was assigned to The Board of Trustees of the Leland Stanford Junior University (Stanford, Calif.) and The Regents of the University of California (San Francisco).

"Methods relating to anti-IL-1 therapy and anti-IL-6 therapy and hypersensitivity" was invented by Vivian E. Saper (Palo Alto, Calif.), Elizabeth D. Mellins (Palo Alto, Calif.) and Jill Hollenbach (San Francisco).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are, inter alia, methods for treating subjects in need of an IL-1 inhibitor therapy or an IL-6 inhibitor therapy, and related methods. The methods include determining whether the subject is at risk...